Based upon the present findings, we hypothesize that developing novel drugs to inhibit required mtDNA replication machinery components, including the helicase Twinkle (encoded by TWNK), SSBP1, and mitochondrial topoisomerases, may represent new therapeutic approaches for cancer treatment and/or prevention. This evidence concerns the gene TWNK and cancer.